A new injectable shows promise to prevent and treat hypoglycemia

byAmerican Chemical SocietyEncapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the horm

Updated on: October 09,2024 0

A new injectable shows promise to prevent and treat hypoglycemia

byAmerican Chemical SocietyEncapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the horm

Updated on:October 09,2024 0

Inhibiting somatostatin may prevent dangerous blood glucose drops in type 1 diabetes

byUniversity of GothenburgImpact of T1D on plasma glucose and pancreatic insulin and glucagon contents in NOD mice. Credit:Nature Metabolism(2024). DOI: 10.1038/s42255-024-01139-zInh

Updated on: October 09,2024 0

Inhibiting somatostatin may prevent dangerous blood glucose drops in type 1 diabetes

byUniversity of GothenburgImpact of T1D on plasma glucose and pancreatic insulin and glucagon contents in NOD mice. Credit:Nature Metabolism(2024). DOI: 10.1038/s42255-024-01139-zInh

Updated on:October 09,2024 0

Patient with type 1 diabetes functionally cured using stem cell injections

by Bob Yirka , Medical XpressCredit:Cell(2024). DOI: 10.1016/j.cell.2024.09.004A team of medical researchers affiliated with a large number of institutions in China has functionally cured

Updated on: October 09,2024 0

Patient with type 1 diabetes functionally cured using stem cell injections

by Bob Yirka , Medical XpressCredit:Cell(2024). DOI: 10.1016/j.cell.2024.09.004A team of medical researchers affiliated with a large number of institutions in China has functionally cured

Updated on:October 09,2024 0

Data show individuals with type 2 diabetes are at higher risk of asthma, and vice versa

byDiabetologiaCredit: Pixabay/CC0 Public DomainIndividuals with type 2 diabetes (T2D) are more likely to develop asthma—and vice versa, according to an analysis of data on 17 million people pres

Updated on: September 30,2024 0

Data show individuals with type 2 diabetes are at higher risk of asthma, and vice versa

byDiabetologiaCredit: Pixabay/CC0 Public DomainIndividuals with type 2 diabetes (T2D) are more likely to develop asthma—and vice versa, according to an analysis of data on 17 million people pres

Updated on:September 30,2024 0

Study reveals how insulin-producing cells work together to respond to metabolic demands

by Emily Packer, George Litchfield,eLifeModulation of individual IPCs by aminergic and peptidergic neurons in patch-clamp recordings. Credit:eLife(2024). DOI: 10.7554/eLife.99548.1Sc

Updated on: September 25,2024 0

Study reveals how insulin-producing cells work together to respond to metabolic demands

by Emily Packer, George Litchfield,eLifeModulation of individual IPCs by aminergic and peptidergic neurons in patch-clamp recordings. Credit:eLife(2024). DOI: 10.7554/eLife.99548.1Sc

Updated on:September 25,2024 0

Large-scale population analysis confirms reassuring safety profile of tirzepatide

Large-scale population analysis confirms reassuring safety profile of tirzepatidebyDiabetologiaCredit: Unsplash/CC0 Public DomainAs more people with type 2 diabetes (T2D) are taking medications

Updated on: September 25,2024 0

Large-scale population analysis confirms reassuring safety profile of tirzepatide

Large-scale population analysis confirms reassuring safety profile of tirzepatidebyDiabetologiaCredit: Unsplash/CC0 Public DomainAs more people with type 2 diabetes (T2D) are taking medications

Updated on:September 25,2024 0

Aussies with type 2 diabetes are missing out on crucial meds, says study

Aussies with type 2 diabetes are missing out on crucial meds, says studyby Kate Burke,University of New South WalesCredit: Nataliya Vaitkevich from PexelsUNSW medical researchers say more Austra

Updated on: September 25,2024 0

Aussies with type 2 diabetes are missing out on crucial meds, says study

Aussies with type 2 diabetes are missing out on crucial meds, says studyby Kate Burke,University of New South WalesCredit: Nataliya Vaitkevich from PexelsUNSW medical researchers say more Austra

Updated on:September 25,2024 0

The Lasker Award: Honoring Medical Innovation

The Lasker Award, often regarded as America’s most prestigious biomedical research accolade, honors individuals who have made significant contributions to the understanding and treatment of diseases.

Updated on: September 24,2024 0

The Lasker Award: Honoring Medical Innovation

The Lasker Award, often regarded as America’s most prestigious biomedical research accolade, honors individuals who have made significant contributions to the understanding and treatment of diseases.

Updated on:September 24,2024 0

Fighting obesity: The GLP-1 revolution

Updated on: September 24,2024 0

Fighting obesity: The GLP-1 revolution

Updated on:September 24,2024 0

Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainNew researchpublishedinNew England Journal of Medicineand presented at this year's Annual Meeting of the European Asso

Updated on: September 23,2024 0

Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainNew researchpublishedinNew England Journal of Medicineand presented at this year's Annual Meeting of the European Asso

Updated on:September 23,2024 0

Tirzepatide associated with greater weight loss in women than men

byDiabetologiaCredit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men,

Updated on: September 23,2024 0

Tirzepatide associated with greater weight loss in women than men

byDiabetologiaCredit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men,

Updated on:September 23,2024 0

Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainIndividuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at

Updated on: September 23,2024 0

Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainIndividuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at

Updated on:September 23,2024 0